Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can we predict how older cancer patients fare after surgery?

NCT ID NCT07412379

Recruiting now Knowledge-focused Sponsor: Hospital Universitario Mayor Méderi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 327 patients aged 65 and older who have surgery to remove gastrointestinal cancer. Researchers want to find out what factors predict whether patients will have a decline in physical function or quality of life one year later, and how they do over five years. The goal is to create a model that helps doctors personalize care for older adults with cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify which older patients are at risk of losing function or quality of life after surgery, leading to better support and care plans.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change outcomes. Results may not apply to all hospitals or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER ABDOMEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

digestive system cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER ABDOMEN ELDERLY (PEOPLE AGED 65 OR MORE) FUNCTIONAL AUTONOMY LEVEL QUALITY OF LIFE SARCOPENIA IN ELDERLY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Universitario Mayor-Méderi

    RECRUITING

    Bogotá, Colombia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.